Definitions
Sorry, no definitions found. You may find more data at victoza.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Victoza.
Examples
-
Patients switching to Victoza experience further reductions in A1c and weight loss Diabetes Care published online the results of the Novo Nordisk (NVO) LEAD ™ 6 extension study, which evaluated the efficacy and safety of switching from exenatide, which is taken twice a day, to once-daily Victoza®.
THE MEDICAL NEWS Editors 2010
-
That's because Victoza, which is manufactured by the pharmaceutical giant Novo Nordisk, is just one of several high-profile diabetes medications on the market.
The Full Feed from HuffingtonPost.com Joe Satran 2012
-
Allegedly, Deen had been taking a different diabetes medication before she inked her $6 million to rep Victoza, which is injected daily.
The Full Feed from HuffingtonPost.com Joe Satran 2012
-
Novo Nordisk's promising new drug for Type-2 diabetes, known as "Victoza," was approved by the FDA on Jan. 26.
Forbes.com: News 2010
-
Novo Nordisk's promising new drug for Type-2 diabetes, known as "Victoza," was approved by the FDA on Jan. 26.
Forbes.com: News John Christy, Forbes International Investment Repo 2010
-
The European Union's drug regulation agency has recommended that the EU approve the marketing of "Victoza" (liraglutide), a type 2 drug developed by Novo Nordisk.
-
Novo, Upping the Ante in the Race for an Oral GLP-1 Drug, Tests a Pill Version of Victoza Type 2 Drugs: EU Approves "Victoza," FDA Extends Review of "Onglyza"
-
New Type 2 Drug, Welchol, Discussed at the AACE Conference Reduces A1c's and LDL Cholesterol Peptide Used to Combat Alzheimer's Found to Be Powerful Insulin Regulator Resolvins, Discovered in Omega-3 Fatty Acids, Show Ability to Restore Lost Gum Disease Tissue and Bone Type 2 Drugs: EU Approves "Victoza," FDA Extends Review of "Onglyza"
-
While insulin sales growth has slowed, sales of Novo Nordisk's new diabetes pill, Victoza, more than tripled to 2.4 billion kroner, or about $440 million, in the first six months of 2011, compared with a year earlier.
The Tough Business of Caring Jeanne Whalen 2011
-
Victoza's label also has a warning about the potential risk of thyroid tumors.
FDA Approves Amylin's Bydureon Diabetes Drug Peter Loftus 2012
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.